Name: Latest research reports of J B Chemicals & Pharmaceuticals Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: J B Chemicals & Pharmaceuticals Ltd.
Rating: 4
Author: ICICI Securities Limited

M&A drives India growth; margins set to surge

Accumulate: J B Chemicals & Pharmaceut...

Target

ICICI Securities Limited

JB Chemicals & Pharmaceuticals’ (JBCPL) Q4FY23 performance was below our expectations due to seasonality in base portfolio of India and M&A-led surge in cost. M&A in India and capacity addition for CMO have lifted sales contribution of these margin-lucrative segments to 65% (55% in FY20).